vida labs semaglutide Micro-Dose vida labs semaglutide GLP-1S/Cagrilintide Blend

Contains Bioperin

IV Therapy Both options deliver nutrients directly into your bloodstream, but they differ in how theyre given

The FDA doesnt have guidelines for microdosing GLP-1 medications and there is a lack of research about the safety and effectiveness of the practice

It is not a systemic anti-ageing intervention, and injecting it is not supported

In January 2025, the FDA approved Ozempic for a third indication : to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular disease-related death in adults with type 2 diabetes and chronic kidney disease

GLP-1 medications work like this hormone, regulating appetite, slowing down digestion, and stimulating insulin production